ScholarIQanswers from OpenAlex
Leningrad Regional Cancer Center
InstitutionResearch output, impact & collaborations
Leningrad Regional Cancer Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about Leningrad Regional Cancer Center?
ScholarIQrecord summary
Leningrad Regional Cancer Center is a research organisation in Saint Petersburg, RU. OpenAlex records 592 works and 22,904 citations for it. 272 researchers list it as their most recent affiliation.
How many works does Leningrad Regional Cancer Center have?
ScholarIQindexed works
Leningrad Regional Cancer Center has 592 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Leningrad Regional Cancer Center have?
ScholarIQcitation count
Leningrad Regional Cancer Center has 22,904 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Leningrad Regional Cancer Center?
ScholarIQresearcher count
Leningrad Regional Cancer Center has 272 researchers in the ScholarIQ index.
What is the average h-index at Leningrad Regional Cancer Center?
ScholarIQavg h-index
Leningrad Regional Cancer Center has an average h-index of 36 in OpenAlex.
What is the ROR of Leningrad Regional Cancer Center?
ScholarIQror
The ROR for Leningrad Regional Cancer Center is on the source record.
What is the OpenAlex record for Leningrad Regional Cancer Center?
ScholarIQopenalex
The OpenAlex for Leningrad Regional Cancer Center is on the source record.
Who are the most-cited researchers behind Leningrad Regional Cancer Center?
ScholarIQtop researchers by citations
What are the most-cited papers on Leningrad Regional Cancer Center?
ScholarIQmost cited works
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
Ying Cheng, Liang Han, Lin Wu, Jun Chen, Hongmei Sun, Guilan Wen, Yinghua Ji, Mikhail Dvorkin, Jianhua Shi, Zhijie Pan, Jinsheng Shi, Xicheng Wang, Yuansong Bai, Tamar Melkadze, Yueyin Pan, Xuhong Min, Maksym Viguro, Xingya Li, Yanqiu Zhao, Junquan Yang, Tamta Makharadze, Ekaterine Arkania, Wenying Kang, Qingyu Wang, Jun Zhu, ASTRUM-005 Study Group, Xiubao Ren, Vladimer Kuchava, Guoping Sun, Gaofeng Li, Lin Wen, Tao Zhang, Hakan Harputluoğlu, İrfan Çiçin, Guosheng Feng, Yanrong Hao, Kejing Ying, Ping Sun, Aihong Zhong, Guangyu An, Yan Wang, Chun Chen, Sheng Yang, Zhendong Chen, Konstantin Penkov, Yuriy Semegen, Oleg Kobziev, Feng Luo, Peiguo Cao, Zhixiong Yang, Min Fan, Wen Li, Robert Mróz, А. Л. Акопов, Tuncay Göksel, Mahmut Gümüş, Wenlei Zhuo, Jian Fang, Hui Zhao, Lin Zhong, Yanping Hu, Yarong Li, Shuqun Zhang, Jiuwei Cui, Н. В. Коваленко, Çağatay Arslan, Devrim Cabuk, Alev Türker, Igor Bondarenko, Yevhen Hotko, O. Goloborodko, Dongji Chen, Mengzhao Wang, Zhuang Yu, Jun‐Guo Lu, Liyan Jiang, Hao Xiong, Davit Giorgadze, Sergey Orlov, Ahmet Bılıcı, Ivan Sinelnikov, Gongyan Chen, Yue Lu, Xiaoli Zhu, Liqin Lu, Mariam Zhvania, Małgorzata Ułańska, Igor Lifirenko, Timur Andabekov, Maria Smagina, Fedor Moiseenko, Yüksel Ürün, Ligong Nie, Bangwei Cao, Zhenyu You, Haixin Huang, Shenpeng Ying, Alexandre Tavartkiladze, Tariel Kitiashvili, Amiran Matitashvili
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
D. Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan W. Goldman, Fedor Moiseenko, Е. А. Филиппова, İrfan Çiçin, Tudor–Eliade Ciuleanu, Nathalie Daaboul, Chunling Liu, Penelope A. Bradbury, Mor Moskovitz, Nuran Katgı, Pascale Tomasini, Alona Zer, Nicolas Girard, Kristof Cuppens, Ji‐Youn Han, Shang‐Yin Wu, Shobhit Baijal, Aaron S. Mansfield, Chih‐Hsi S. Kuo, Kazumi Nishino, Se‐Hoon Lee, David Planchard, Christina S. Baik, Martha Li, Peter Ansell, Summer Xia, Ellen Bolotin, Jim Looman, Christine K. Ratajczak, Shun Lü
Investigation of the mechanisms of resistance to osimertinib in patients with T790M-associated NSCLC
M. Stepanova, Fedor Moiseenko, A.S. Zhabina, В. В. Клименко, N. Rysev, A.V. Myslik, E.V. Artemieva, Ksenya V. Shelekhova, An.A. Bogdanov, Nikita Volkov, В. Моисеенко
How much of the research on Leningrad Regional Cancer Center is open access?
ScholarIQopen access share
100%OPEN ACCESS